Selección de DES para Diabéticos: Análisis de evidencias


Mariano Albertal
2012-10-04

More articles by this author

Intervenciones coronarias: optimizando la farmacología

Conrad Simpfendorfer.2012-10-04

¿Qué tanto nos adherimos a las guidelines AHA?

Dario Echeverri 2012-10-04

Hybrid coronary revascularization: is this in your future?

César Mendoza2012-10-04

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...